80 related articles for article (PubMed ID: 2439831)
21. Role of nitric oxide in the contractile response to 5-hydroxytryptamine of the basilar artery from Wistar Kyoto and stroke-prone rats.
Salomone S; Morel N; Godfraind T
Br J Pharmacol; 1997 Jul; 121(6):1051-8. PubMed ID: 9249238
[TBL] [Abstract][Full Text] [Related]
22. Magnesium deficiency produces endothelium-dependent vasorelaxation in canine coronary arteries.
Ku DD; Ann HS
J Pharmacol Exp Ther; 1987 Jun; 241(3):961-6. PubMed ID: 3598912
[TBL] [Abstract][Full Text] [Related]
23. [Nimodipine, nifedipine and the cerebrovascular effects of serotonin].
Semkina GA; Matsievskiĭ DD; Mirzoian RS
Eksp Klin Farmakol; 1996; 59(6):13-6. PubMed ID: 9181863
[TBL] [Abstract][Full Text] [Related]
24. Effect of ageing on the passive and active tension and pharmacodynamic characteristics of rat coronary arteries: age-dependent increase in sensitivity to 5-HT and K+.
Sheykhzade M; Simonsen AH; Boonen HC; Outzen EM; Nyborg NC
Pharmacology; 2012; 90(3-4):160-8. PubMed ID: 22922218
[TBL] [Abstract][Full Text] [Related]
25. Specificity of action of Ca++ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries.
Godfraind T; Miller RC
Circ Res; 1983 Feb; 52(2 Pt 2):I81-91. PubMed ID: 6831654
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the vasoconstrictor responses to potassium depolarization and norepinephrine and their antagonism by differing classes of vasodilators in the perfused rat hindquarters.
Sybertz EJ; Vander Vliet G; Baum T
J Pharmacol Exp Ther; 1983 Dec; 227(3):621-6. PubMed ID: 6317841
[TBL] [Abstract][Full Text] [Related]
27. In vitro effects of nifedipine, nisoldipine, and lacidipine on rat isolated coronary small arteries.
Pfaffendorf M; Mathy MJ; van Zwieten PA
J Cardiovasc Pharmacol; 1993 Mar; 21(3):496-502. PubMed ID: 7681514
[TBL] [Abstract][Full Text] [Related]
28. The mechanisms of the direct action of etomidate on vascular reactivity in rat mesenteric resistance arteries.
Shirozu K; Akata T; Yoshino J; Setoguchi H; Morikawa K; Hoka S
Anesth Analg; 2009 Feb; 108(2):496-507. PubMed ID: 19151278
[TBL] [Abstract][Full Text] [Related]
29. In vitro studies on responses to noradrenaline, serotonin, and potassium of intramyocardial and mesenteric resistance vessels from Wistar rats.
Nyborg NC; Mikkelsen EO
J Cardiovasc Pharmacol; 1985; 7(3):417-23. PubMed ID: 2410669
[TBL] [Abstract][Full Text] [Related]
30. Effects of manidipine and other calcium antagonists on rat renal arcuate arteries.
Pfaffendorf M; Mathy MJ; van Zwieten PA
Am Heart J; 1993 Feb; 125(2 Pt 2):571-7. PubMed ID: 8430602
[TBL] [Abstract][Full Text] [Related]
31. A nimodipine-resistant Ca2+ pathway is involved in myogenic tone in a resistance artery.
Hwa JJ; Bevan JA
Am J Physiol; 1986 Jul; 251(1 Pt 2):H182-9. PubMed ID: 2942041
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of vasoconstrictor and attenuation of vasodilator effects of 5-hydroxytryptamine by the calcium channel blockers nimodipine and nifedipine in the pig.
Duncker DJ; Yland MJ; Van der Weij LP; Saxena PR; Verdouw PD
Eur J Pharmacol; 1987 Apr; 136(1):11-21. PubMed ID: 3595710
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders.
Jansen I; Tfelt-Hansen P; Edvinsson L
Eur J Clin Pharmacol; 1991; 40(1):7-15. PubMed ID: 2060549
[TBL] [Abstract][Full Text] [Related]
34. Effects of nifedipine on contractile responses to potassium, histamine, and 5-hydroxytryptamine in isolated human pulmonary vessels.
Mikkelsen EO; Sakr AM; Jespersen LT
J Cardiovasc Pharmacol; 1983; 5(2):317-20. PubMed ID: 6188909
[TBL] [Abstract][Full Text] [Related]
35. Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones.
Mercuri NB; Bonci A; Calabresi P; Stratta F; Stefani A; Bernardi G
Br J Pharmacol; 1994 Nov; 113(3):831-8. PubMed ID: 7858874
[TBL] [Abstract][Full Text] [Related]
36. Nimodipine has an inhibitory action on neurotransmitter release from human cerebral arteries.
Porter ID; Gardiner IM; de Belleroche J
J Cereb Blood Flow Metab; 1985 Jun; 5(2):338-42. PubMed ID: 3988833
[TBL] [Abstract][Full Text] [Related]
37. Cerebral arterial spasm: part 9. In vitro effects of nifedipine on serotonin-, phenylephrine-, and potassium-induced contractions of canine basilar and femoral arteries.
Allen GS; Banghart SB
Neurosurgery; 1979 Jan; 4(1):37-42. PubMed ID: 450213
[TBL] [Abstract][Full Text] [Related]
38. Survival-promoting activity of nimodipine and nifedipine in rat motoneurons: implications of an intrinsic calcium toxicity in motoneurons.
Arakawa Y; Nishijima C; Shimizu N; Urushidani T
J Neurochem; 2002 Oct; 83(1):150-6. PubMed ID: 12358738
[TBL] [Abstract][Full Text] [Related]
39. The actions of nifedipine and nisoldipine on the contractile activity of human coronary arteries and human cardiac tissue in vitro.
Godfraind T; Eglème C; Finet M; Jaumin P
Pharmacol Toxicol; 1987 Aug; 61(2):79-84. PubMed ID: 3671330
[TBL] [Abstract][Full Text] [Related]
40. Serotonin response increases with age in rat coronary resistance arteries.
Nyborg NC; Mikkelsen EO
Cardiovasc Res; 1988 Feb; 22(2):131-7. PubMed ID: 3167935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
